ArticleCancer medicine2015

Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.

Esther N Oliva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.